IPA
Price
$0.47
Change
+$0.03 (+6.82%)
Updated
Apr 24, 04:57 PM (EDT)
Capitalization
21.23M
KOD
Price
$4.19
Change
+$0.20 (+5.01%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
210.53M
25 days until earnings call
Ad is loading...

IPA vs KOD

Header iconIPA vs KOD Comparison
Open Charts IPA vs KODBanner chart's image
ImmunoPrecise Antibodies
Price$0.47
Change+$0.03 (+6.82%)
Volume$191
Capitalization21.23M
Kodiak Sciences
Price$4.19
Change+$0.20 (+5.01%)
Volume$1.14K
Capitalization210.53M
IPA vs KOD Comparison Chart
Loading...
IPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPA vs. KOD commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPA is a StrongBuy and KOD is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (IPA: $0.44 vs. KOD: $3.99)
Brand notoriety: IPA and KOD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPA: 31% vs. KOD: 206%
Market capitalization -- IPA: $21.23M vs. KOD: $210.53M
IPA [@Biotechnology] is valued at $21.23M. KOD’s [@Biotechnology] market capitalization is $210.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPA’s FA Score shows that 1 FA rating(s) are green whileKOD’s FA Score has 1 green FA rating(s).

  • IPA’s FA Score: 1 green, 4 red.
  • KOD’s FA Score: 1 green, 4 red.
According to our system of comparison, both IPA and KOD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPA’s TA Score shows that 6 TA indicator(s) are bullish while KOD’s TA Score has 4 bullish TA indicator(s).

  • IPA’s TA Score: 6 bullish, 2 bearish.
  • KOD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IPA is a better buy in the short-term than KOD.

Price Growth

IPA (@Biotechnology) experienced а +3.98% price change this week, while KOD (@Biotechnology) price change was +69.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

IPA is expected to report earnings on Mar 28, 2025.

KOD is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KOD($211M) has a higher market cap than IPA($21.2M). IPA YTD gains are higher at: 7.846 vs. KOD (-59.899). IPA has higher annual earnings (EBITDA): -45.11M vs. KOD (-164.93M). KOD has more cash in the bank: 198M vs. IPA (12.9M). IPA has less debt than KOD: IPA (12.9M) vs KOD (73.4M). IPA has higher revenues than KOD: IPA (24M) vs KOD (0).
IPAKODIPA / KOD
Capitalization21.2M211M10%
EBITDA-45.11M-164.93M27%
Gain YTD7.846-59.899-13%
P/E RatioN/AN/A-
Revenue24M0-
Total Cash12.9M198M7%
Total Debt12.9M73.4M18%
FUNDAMENTALS RATINGS
IPA vs KOD: Fundamental Ratings
IPA
KOD
OUTLOOK RATING
1..100
2927
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
6459
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IPA's Valuation (23) in the null industry is in the same range as KOD (27) in the Biotechnology industry. This means that IPA’s stock grew similarly to KOD’s over the last 12 months.

IPA's Profit vs Risk Rating (100) in the null industry is in the same range as KOD (100) in the Biotechnology industry. This means that IPA’s stock grew similarly to KOD’s over the last 12 months.

KOD's SMR Rating (95) in the Biotechnology industry is in the same range as IPA (96) in the null industry. This means that KOD’s stock grew similarly to IPA’s over the last 12 months.

KOD's Price Growth Rating (59) in the Biotechnology industry is in the same range as IPA (64) in the null industry. This means that KOD’s stock grew similarly to IPA’s over the last 12 months.

KOD's P/E Growth Rating (100) in the Biotechnology industry is in the same range as IPA (100) in the null industry. This means that KOD’s stock grew similarly to IPA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IPAKOD
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 24 days ago
90%
Bearish Trend 17 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
IPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMFVX14.91N/A
N/A
MassMutual Equity Opports Adm
HNLVX20.30N/A
N/A
Harbor Large Cap Value Retirement
RYPAX41.85N/A
N/A
Rydex Transportation H
HAGIX66.85N/A
N/A
Carillon Eagle Mid Cap Growth I
RSMRX13.69N/A
N/A
RBC SMID Cap Growth R6

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with RCKT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+9.62%
RCKT - KOD
50%
Loosely correlated
+2.44%
RGNX - KOD
47%
Loosely correlated
+13.43%
XNCR - KOD
46%
Loosely correlated
+2.07%
IMNM - KOD
44%
Loosely correlated
+3.54%
KYMR - KOD
43%
Loosely correlated
+6.56%
More